IGM Biosciences Ownership | Who Owns IGM Biosciences?


OverviewForecastRevenueFinancialsChart

IGM Biosciences Ownership Summary


IGM Biosciences is owned by 37.03% institutional investors, 35.12% insiders, and 27.84% retail investors. Baker bros. advisors lp is the largest institutional shareholder, holding 6.80% of IGMS shares. T. Rowe Price New Horizons is the top mutual fund, with 3.32% of its assets in IGM Biosciences shares.

IGMS Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockIGM Biosciences37.03%35.12%27.84%
SectorHealthcare Stocks 47.06%8.01%44.93%
IndustryBiotech Stocks 44.97%7.82%47.21%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Baker bros. advisors lp4.09M6.80%$28.10M
Price t rowe associates inc /md/4.08M6.78%$28.00M
Artal group3.33M5.54%$22.88M
Redmile group3.07M5.11%$21.11M
Goldman sachs group1.33M2.22%$9.16M
Blackrock883.08K1.47%$6.07M
Vanguard group878.62K1.46%$6.04M
Fmr818.87K1.36%$5.63M
State street457.62K0.76%$3.14M
Geode capital management367.68K0.61%$2.53M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Redmile group3.07M1.28%$21.11M
Artal group3.33M0.58%$22.88M
Baker bros. advisors lp4.09M0.36%$28.10M
Corton capital63.34K0.23%$435.12K
Bruce100.00K0.23%$687.00K
Eagle bay advisors44.63K0.19%$306.64K
Rhenman & partners asset management ab195.00K0.13%$1.34M
Virtus etf advisers11.40K0.04%$78.33K
Gsa capital partners llp61.98K0.03%$426.00K
Quest partners11.91K0.01%$81.84K

Top Buyers

HolderShares% AssetsChange
Artal group3.33M0.58%250.00K
Price t rowe associates inc /md/4.08M0.00%187.07K
State street457.62K0.00%138.35K
Blackrock883.08K0.00%125.12K
Corton capital63.34K0.23%63.34K

Top Sellers

HolderShares% AssetsChange
Ra capital management---937.50K
Fmr818.87K0.00%-498.47K
Samsara biocapital---154.66K
Marshall wace, llp---107.27K
Jacobs levy equity management---78.58K

New Positions

HolderShares% AssetsChangeValue
Corton capital63.34K0.23%63.34K$435.12K
Millennium management30.00K0.00%30.00K$206.10K
Susquehanna group, llp12.60K-12.60K$86.56K
Aqr capital management12.23K0.00%12.23K$84.02K
Corebridge financial8.16K0.00%8.16K$56.07K

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-3.00
Advisor group-59.00
Gamma investing-76.00
Quarry lp-197.00
Hanseatic management services-366.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202485-3.41%22,262,728-2.42%372.55%5310.42%15-28.57%
Mar 31, 20248818.92%22,815,5464.28%382.83%4829.73%21-
Dec 31, 202374-8.64%21,879,400-1.96%361.50%37-11.90%21-4.55%
Sep 30, 202381-1.22%22,316,9700.26%491.97%42-25.00%2229.41%
Jun 30, 2023825.13%22,259,30424.70%503.11%5647.37%17-34.62%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
T. Rowe Price New Horizons1.97M3.32%-6.20K
US Small-Cap Growth II Equity Comp1.97M3.32%-6.99K
T. Rowe Price Health Sciences849.75K1.43%-5.66K
Fidelity Select Biotechnology809.98K1.37%-
Vanguard Total Stock Mkt Idx Inv461.05K0.78%-
iShares Russell 2000 ETF401.29K0.68%-896.00
T. Rowe Price New Horizons Tr-Z396.15K0.67%12.79K
Vanguard Institutional Extnd Mkt Idx Tr258.93K0.44%-1.97K
Invesco Dorsey Wright SmallCap Momt ETF216.42K0.36%-
State St Russell Sm/Mid Cp® Indx NL Cl C196.29K0.33%-28.34K

Recent Insider Transactions


DateNameRoleActivityValue
Sep 13, 2024Weber Steven PRINCIPAL ACCOUNTING OFFICERSell$5.41K
Sep 13, 2024Takimoto Chris H CHIEF MEDICAL OFFICERSell$17.16K
Sep 13, 2024Tahir Misbah CHIEF FINANCIAL OFFICERSell$17.16K
Sep 13, 2024Schwarzer Fred CEO AND PRESIDENTSell$45.53K
Sep 13, 2024Keyt Bruce CHIEF SCIENTIFIC OFFICERSell$17.16K

Insider Transactions Trends


DateBuySell
2024 Q4--
2024 Q3-8
2024 Q2-7
2024 Q1812
2023 Q41210

IGMS Ownership FAQ


Who Owns IGM Biosciences?

IGM Biosciences shareholders are primarily institutional investors at 37.03%, followed by 35.12% insiders and 27.85% retail investors. The average institutional ownership in IGM Biosciences's industry, Biotech Stocks , is 44.97%, which IGM Biosciences falls below.

Who owns the most shares of IGM Biosciences?

IGM Biosciences’s largest shareholders are Baker bros. advisors lp (4.09M shares, 6.80%), Price t rowe associates inc /md/ (4.08M shares, 6.78%), and Artal group (3.33M shares, 5.54%). Together, they hold 19.12% of IGM Biosciences’s total shares outstanding.

Does Blackrock own IGM Biosciences?

Yes, BlackRock owns 1.47% of IGM Biosciences, totaling 883.08K shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 6.07M$. In the last quarter, BlackRock increased its holdings by 125.12K shares, a 16.51% change.

Who is IGM Biosciences’s biggest shareholder by percentage of total assets invested?

Redmile group is IGM Biosciences’s biggest shareholder by percentage of total assets invested, with 1.28% of its assets in 3.07M IGM Biosciences shares, valued at 21.11M$.

Who is the top mutual fund holder of IGM Biosciences shares?

T. Rowe Price New Horizons is the top mutual fund holder of IGM Biosciences shares, with 3.32% of its total shares outstanding invested in 1.97M IGM Biosciences shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools